Volition Develops a New Improved Nu.Q™ Assay Format
VolitionRx Completes Acquisition of Octamer GmbH
VolitionRx Limited Announces Strategic Acquisition
VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test
VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia
VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update
VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update
Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas
